000 01514 a2200421 4500
005 20250516155530.0
264 0 _c20140213
008 201402s 0 0 eng d
022 _a1791-3004
024 7 _a10.3892/mmr.2013.1554
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aGuo, Run-Min
245 0 0 _aActivation of the p38 MAPK/NF-κB pathway contributes to doxorubicin-induced inflammation and cytotoxicity in H9c2 cardiac cells.
_h[electronic resource]
260 _bMolecular medicine reports
_cAug 2013
300 _a603-8 p.
_bdigital
500 _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't
650 0 4 _aAnimals
650 0 4 _aDoxorubicin
_xtoxicity
650 0 4 _aEnzyme Activation
_xdrug effects
650 0 4 _aInflammation
_xchemically induced
650 0 4 _aMyocytes, Cardiac
_xdrug effects
650 0 4 _aNF-kappa B
_xmetabolism
650 0 4 _aPhosphorylation
_xdrug effects
650 0 4 _aRats
650 0 4 _aSignal Transduction
_xdrug effects
650 0 4 _aTranscription Factor RelA
_xmetabolism
650 0 4 _ap38 Mitogen-Activated Protein Kinases
_xmetabolism
700 1 _aXu, Wen-Ming
700 1 _aLin, Jian-Cong
700 1 _aMo, Li-Qiu
700 1 _aHua, Xiao-Xiao
700 1 _aChen, Pei-Xi
700 1 _aWu, Keng
700 1 _aZheng, Dong-Dan
700 1 _aFeng, Jian-Qiang
773 0 _tMolecular medicine reports
_gvol. 8
_gno. 2
_gp. 603-8
856 4 0 _uhttps://doi.org/10.3892/mmr.2013.1554
_zAvailable from publisher's website
999 _c22872748
_d22872748